Kyongbo Pharmaceutical Co Ltd
KRX:214390

Watchlist Manager
Kyongbo Pharmaceutical Co Ltd Logo
Kyongbo Pharmaceutical Co Ltd
KRX:214390
Watchlist
Price: 6 080 KRW 1% Market Closed
Market Cap: ₩145.4B

Operating Margin

2.4%
Current
Declining
by 0.5%
vs 3-y average of 2.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.4%
=
Operating Income
₩6B
/
Revenue
₩252.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.4%
=
Operating Income
₩6B
/
Revenue
₩252.2B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Kyongbo Pharmaceutical Co Ltd
KRX:214390
143.9B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
969.6B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.3B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
48th
Based on 2 615 companies
48th percentile
2.4%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Kyongbo Pharmaceutical Co Ltd
Glance View

Market Cap
145.4B KRW
Industry
Pharmaceuticals

KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Asan, Chungcheongnam-Do. The company went IPO on 2015-06-29. The firm distributes its products within domestic market and to overseas markets including China Japan and Europe.

Kyongbo Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
2.4%
=
Operating Income
₩6B
/
Revenue
₩252.2B
What is Kyongbo Pharmaceutical Co Ltd's current Operating Margin?

The current Operating Margin for Kyongbo Pharmaceutical Co Ltd is 2.4%, which is below its 3-year median of 2.9%.

How has Operating Margin changed over time?

Over the last 3 years, Kyongbo Pharmaceutical Co Ltd’s Operating Margin has increased from -3.2% to 2.4%. During this period, it reached a low of -3.2% on Aug 30, 2022 and a high of 4.4% on Dec 31, 2024.

Back to Top